Radioligand Therapy’s Impact on Neuroendocrine Tumors
In the evolving landscape of oncology, the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) remains a crucial challenge. Understanding the mechanisms and advancements in treatment modalities...
















